Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TNON
TNON logo

TNON Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Tenon Medical Inc (TNON) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.770
1 Day change
3.92%
52 Week Range
2.800
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Tenon Medical Inc (TNON) is not a strong buy for a beginner investor with a long-term strategy at this time. Despite some positive financial growth trends, the stock's technical indicators, lack of trading signals, and absence of strong catalysts suggest a neutral position is more appropriate.

Technical Analysis

The MACD is slightly positive and expanding, but RSI is neutral at 48.646, indicating no clear momentum. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5. The stock is trading near its pivot level of 0.726, with resistance at 0.771 and support at 0.682. Overall, the technical setup does not indicate a strong buy opportunity.

Positive Catalysts

  • Revenue increased by 32.24% YoY in Q3 2025, and gross margin improved significantly by 39.83% YoY to 65.9%.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from insiders or hedge funds. Stock trend analysis suggests a potential decline of -3.05% in the next week.

Financial Performance

In Q3 2025, revenue grew by 32.24% YoY to $1,173,000, and gross margin improved to 65.9%. However, the company remains unprofitable, with a net income of -$3,339,000 and a significant EPS decline of -88.98% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes available for this stock.

Wall Street analysts forecast TNON stock price to rise
2 Analyst Rating
Wall Street analysts forecast TNON stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.769
sliders
Low
2.5
Averages
2.75
High
3
Current: 0.769
sliders
Low
2.5
Averages
2.75
High
3
Alliance Global
Buy
downgrade
AI Analysis
2025-11-14
Reason
Alliance Global
Price Target
AI Analysis
2025-11-14
downgrade
Buy
Reason
Alliance Global lowered the firm's price target on Tenon Medical to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm's revised target reflects lower forecasts following the company's Q3 report.
Alliance Global Partners
Buy
downgrade
$3
2025-05-14
Reason
Alliance Global Partners
Price Target
$3
2025-05-14
downgrade
Buy
Reason
Alliance Global Partners lowered the firm's price target on Tenon Medical to $2.50 from $3 and keeps a Buy rating on the shares, citing lower forecasts after Tenon reported Q1 results that were within the firm's expectations, including a revenue shortfall offset by lower expenses.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TNON
Unlock Now

People Also Watch